HSPA1A and neurodegenerative disease: As such, boosting HSP transcription has been considered as a therapeutic strategy for neurodegenerative diseases, but has had limited clinical success 125–128, and has focused particularly on HSPA1A, which is not upregulated in neurons under most conditions 72,125,126.